Compound Evidence File
#EC-2026-0228
Turinabol
Filed under Oral Tablets. The bureau holds 179 laboratory returns for this compound from 64 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
64 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Mar 2026 | 13 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 23 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Feb 2026 | 10 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 10 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Mar 2026 | 6 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Feb 2026 | 14 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 5 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Mar 2026 | 9 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 11 Dec 2025 | 3 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 15 Apr 2026 | 11 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 20 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Apr 2026 | 16 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Apr 2026 | 20 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 18 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 9.9 | 6 Mar 2026 | 16 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 9.9 | 22 Mar 2026 | 12 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 9.9 | 18 Jun 2026 | 8 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jun 2026 | 2 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 21 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Jun 2026 | 13 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Apr 2026 | 21 Jul 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 9.7 | 9.7 | 9.7 | 27 Feb 2025 | 27 Feb 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 9.6 | 9.6 | 9.6 | 13 Feb 2025 | 13 Feb 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 9.4 | 8.9 | 10.0 | 7 May 2025 | 24 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 9.4 | 9.4 | 9.4 | 20 Jun 2025 | 20 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 8.8 | 7.0 | 9.8 | 23 May 2026 | 23 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 | 8 Jul 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 | 8 Jul 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 | 8 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.5 | 7.4 | 9.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.4 | 7.1 | 10.0 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.4 | 7.6 | 9.0 | 24 May 2026 | 24 May 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 | 6 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.2 | 7.3 | 9.4 | 24 May 2026 | 24 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 8.2 | 6.3 | 10.0 | 24 Apr 2025 | 20 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 10 | 8.0 | 5.6 | 10.0 | 28 Mar 2025 | 24 May 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 7 | 7.8 | 5.0 | 10.0 | 27 Feb 2025 | 17 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 8 | 7.7 | 6.7 | 9.3 | 3 Jun 2025 | 17 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 7.5 | 7.5 | 7.5 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 | 20 Jun 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 | 16 Mar 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 | 6 May 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.7 | 6.7 | 6.7 | 6 May 2025 | 6 May 2025 |
| OupeptideCASE #VI-2026-0435 | X | 9 | 6.4 | 3.7 | 9.3 | 3 Jun 2025 | 21 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 | 20 Jun 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jun 2025 | 3 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 5 | 5.9 | 5.2 | 6.6 | 28 Mar 2025 | 17 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 1 | 5.9 | 5.9 | 5.9 | 7 May 2025 | 7 May 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 5.7 | 5.7 | 5.7 | 3 Jul 2025 | 3 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 4.8 | 3.9 | 6.2 | 11 Jun 2025 | 17 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 4.7 | 4.7 | 4.7 | 2 Apr 2025 | 2 Apr 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 4.5 | 4.5 | 4.5 | 7 May 2025 | 7 May 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 4.3 | 4.3 | 4.3 | 21 May 2025 | 21 May 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 4.2 | 3.6 | 4.9 | 16 Mar 2025 | 21 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 3.0 | 3.0 | 3.0 | 8 Jul 2025 | 8 Jul 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 2.8 | 2.8 | 2.8 | 24 Apr 2025 | 24 Apr 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 2.2 | 2.2 | 2.2 | 27 Feb 2025 | 27 Feb 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 2.2 | 2.2 | 2.2 | 8 Jul 2025 | 8 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.7 | 0.7 | 0.7 | 14 Jan 2025 | 14 Jan 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.5 | 0.5 | 0.5 | 20 Jun 2025 | 20 Jun 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
Open any subject to view the batch-level evidence for Turinabol alone.